Grants per year
Personal profile
Research Interests
My primary interests are in developing novel therapeutic combinations for the treatment of gastrointestinal cancers. I am interested in incorporating immunotherapy and molecular testing into clinical trials.
Training Experience
| 2009 | Residency, St. Vincents Hospital, Melbourne Australia |
| 2011 | Residency, University Hospitals Case Medical Center, Cleveland OH |
| 2014 | Fellowship, University of Pittsburgh Medical Center |
| 2014 | Fellowship, Northwestern University |
Expertise related to UN Sustainable Devlopment Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Education/Academic qualification
Medicine, MBBS, Flinders University
… → 2005
Research interests
- Cancer Biology
- Colon / Rectal Cancer
- Nanotechnology
- Pancreatic Cancer
Fingerprint
Dive into the research topics where Aparna Kalyan is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Prot #YO39609: A Phase Ib/II, Open-Label, Multicenter, Randomized, Umbrella Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatment Combinations in Patients with Locally Advanced Unresectable or Metastatic Gastric or Gastroesoph
Covance Inc., Genentech, Inc. and Hoffmann-La Roche Inc.
4/2/21 → 4/2/24
Project: Research project
-
Prot #DEK-DKK1-P206: Expanded Access Use of DKN-01 for the Treatment of Advanced Solid Tumors
Early Access Care, LLC, Leap Therapeutics, Inc.
12/18/20 → 12/18/23
Project: Research project
-
Prot #QBGJ398-301: A Phase 3 Multicenter, Open-Label, Randomized, Controlled Study of Oral Infigratinib versus Gemcitabine with Cisplatin in Subjects with Advanced/Metastatic or Inoperable Cholangiocarcinoma with FGFR2 Gene Fusions/Translocations: The PRO
PPD Investigator Services, LLC, QED Therapeutics, Inc.
10/2/20 → 10/2/23
Project: Research project
-
Comparing Real World, Personalized, Multidisciplinary Tumor Board Recommendations with BCLC Algorithm: 321-Patient Analysis
Matsumoto, M. M., Mouli, S., Saxena, P., Gabr, A., Riaz, A., Kulik, L., Ganger, D., Maddur, H., Boike, J., Flamm, S., Moore, C., Kalyan, A., Desai, K., Thornburg, B., Abecassis, M., Hickey, R., Caicedo, J., Grace, K., Lewandowski, R. J. & Salem, R., Jul 2021, In: Cardiovascular and Interventional Radiology. 44, 7, p. 1070-1080 11 p.Research output: Contribution to journal › Article › peer-review
2 Scopus citations -
Epidemiology, mutational landscape and staging of hepatocellular carcinoma
Fenton, S. E., Burns, M. C. & Kalyan, A., 2021, In: Chinese clinical oncology. 10, 1, 2.Research output: Contribution to journal › Review article › peer-review
Open Access -
Ipilimumab and Gemcitabine for Advanced Pancreatic Cancer: A Phase Ib Study
Kamath, S. D., Kalyan, A., Kircher, S., Nimeiri, H., Fought, A. J., Benson, A. & Mulcahy, M., May 1 2020, In: Oncologist. 25, 5, p. e808-e815Research output: Contribution to journal › Article › peer-review
28 Scopus citations -
Streamlining radioembolization in UNOS T1/T2 hepatocellular carcinoma by eliminating lung shunt estimation
Gabr, A., Ranganathan, S., Mouli, S. K., Riaz, A., Gates, V. L., Kulik, L., Ganger, D., Maddur, H., Moore, C., Hohlastos, E., Katariya, N., Caicedo, J. C., Kalyan, A., Lewandowski, R. J. & Salem, R., Jun 2020, In: Journal of Hepatology. 72, 6, p. 1151-1158 8 p.Research output: Contribution to journal › Article › peer-review
10 Scopus citations -
A Case of Metastatic Biliary Tract Cancer Diagnosed Through Identification of an IDH1 Mutation
Kamath, S. D., Lin, X. & Kalyan, A., Feb 2019, In: Oncologist. 24, 2, p. 151-156 6 p.Research output: Contribution to journal › Article › peer-review
1 Scopus citations